Serum neurofilament light at diagnosis: a prognostic indicator for accelerated disease progression in Parkinson’s Disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Serum neurofilament light at diagnosis: a prognostic indicator for accelerated disease progression in Parkinson’s Disease ; volume:10 ; number:1 ; day:21 ; month:8 ; year:2024 ; pages:1-6 ; date:12.2024
npj Parkinson's Disease ; 10, Heft 1 (21.8.2024), 1-6, 12.2024

Creator: Pedersen, Camilla Christina
Ushakova, Anastasia
Alves, Guido
Tysnes, Ole-Bjørn
Blennow, Kaj
Zetterberg, Henrik
Maple-Grødem, Jodi
Lange, Johannes

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41531-024-00768-1

URN: urn:nbn:de:101:1-2411072059365.680742938487

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:28 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Pedersen, Camilla Christina
Ushakova, Anastasia
Alves, Guido
Tysnes, Ole-Bjørn
Blennow, Kaj
Zetterberg, Henrik
Maple-Grødem, Jodi
Lange, Johannes
SpringerLink (Online service)

Other Objects (12)

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Fluid biomarkers in Alzheimer’s disease – current concepts

Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease

BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease

Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression

Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions

Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Fluid biomarkers in Alzheimer’s disease – current concepts

Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease

BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease

Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression

Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions

Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Fluid biomarkers in Alzheimer’s disease – current concepts

Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease

BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease

Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression

Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions

Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Serum neurofilament light at diagnosis: a prognostic indicator for accelerated disease progression in Parkinson’s Disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Fluid biomarkers in Alzheimer’s disease – current concepts

Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease

BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease

Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression

Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions

Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Fluid biomarkers in Alzheimer’s disease – current concepts

Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease

BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease

Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression

Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions

Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Fluid biomarkers in Alzheimer’s disease – current concepts

Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease

BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease

Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression

Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions

Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury

Related objects

Reset password